UNSPSC 51181613: Calcitonin

This classification denotes a peptide hormone with the molecular formula C145H240N44O48S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DF35I47HCM, more generally known as calcitonin. European Medicines Agency schedules calcitonin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00948MIG. The term CALCITONIN is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 13 no. 1, 1999, list 41.

CALCITONIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule calcitonin under HS 29371900 and SITC 54154. As of Q4 2014, CALCITONIN remains the US FDA Preferred Term for this commodity. Calcitonin bears US NLM identifiers UMLS ID C0006668 and NCI Concept Code C2281.

UNSPSC 51181613 Calcitonin is a Commodity code for a pharmaceutical hormone treatment used in state and local healthcare procurement, particularly in hospital systems, public health departments, and correctional facilities that manage patient populations requiring bone-metabolism therapy. Calcitonin is a synthetic or natural hormone administered to treat osteoporosis, hypercalcemia, and Paget's disease; state and local healthcare buyers procure it as a formulary drug through pharmaceutical wholesalers, group purchasing organizations, or direct contracts with manufacturers. The issuing-body mix spans state departments of health, county hospital systems, municipal healthcare facilities, and state and federal correctional departments that stock calcitonin in pharmacy inventories or outpatient clinics.

The source provides no recent state and local contract opportunities tagged to this code.